The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

John G. Nutt

Department of Neurology

Oregon Health and Science University


OR 97239



Name/email consistency: high



  • Department of Neurology, Oregon Health and Science University, Portland, OR 97239, USA. 2000 - 2010
  • Department of Neurology, Oregon Health & Science University, Parkinson Disease Research, Education and Clinical Center, USA. 2008
  • Department of Neurology, and Public Health and Preventative Medicine, Division of Biostatistics, Oregon Health and Science University, USA. 2007


  1. Dyskinesia and the antiparkinsonian response always temporally coincide: a retrospective study. Nutt, J.G., Chung, K.A., Holford, N.H. Neurology (2010) [Pubmed]
  2. Pharmacokinetics and pharmacodynamics of levodopa. Nutt, J.G. Mov. Disord. (2008) [Pubmed]
  3. Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism. Nutt, J.G., Gunzler, S.A., Kirchhoff, T., Hogarth, P., Weaver, J.L., Krams, M., Jamerson, B., Menniti, F.S., Landen, J.W. Mov. Disord. (2008) [Pubmed]
  4. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial. Nutt, J.G., Carter, J.H., Carlson, N.E. Arch. Neurol. (2007) [Pubmed]
  5. Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?. Nutt, J.G. Mov. Disord. (2007) [Pubmed]
  6. Clinical practice. Diagnosis and initial management of Parkinson's disease. Nutt, J.G., Wooten, G.F. N. Engl. J. Med. (2005) [Pubmed]
  7. The dopamine transporter: importance in Parkinson's disease. Nutt, J.G., Carter, J.H., Sexton, G.J. Ann. Neurol. (2004) [Pubmed]
  8. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Nutt, J.G., Burchiel, K.J., Comella, C.L., Jankovic, J., Lang, A.E., Laws, E.R., Lozano, A.M., Penn, R.D., Simpson, R.K., Stacy, M., Wooten, G.F. Neurology (2003) [Pubmed]
  9. Evolution of the response to levodopa during the first 4 years of therapy. Nutt, J.G., Carter, J.H., Lea, E.S., Sexton, G.J. Ann. Neurol. (2002) [Pubmed]
  10. DBS and diathermy interaction induces severe CNS damage. Nutt, J.G., Anderson, V.C., Peacock, J.H., Hammerstad, J.P., Burchiel, K.J. Neurology (2001) [Pubmed]
  11. Motor fluctuations and dyskinesia in Parkinson's disease. Nutt, J.G. Parkinsonism Relat. Disord. (2001) [Pubmed]
  12. Interactions between deep brain stimulation and levodopa in Parkinson's disease. Nutt, J.G., Rufener, S.L., Carter, J.H., Anderson, V.C., Pahwa, R., Hammerstad, J.P., Burchiel, K.J. Neurology (2001) [Pubmed]
  13. Apomorphine can sustain the long-duration response to L-DOPA in fluctuating PD. Nutt, J.G., Carter, J.H. Neurology (2000) [Pubmed]
WikiGenes - Universities